REXO2 and adrenal gland pheochromocytoma: Loss of heterozygosity at 11q23, the location of the REXO2 gene, has been described in PCC (Sun et al., 2006), a known mechanism that may serve to inactivate the wild-type allele and may contribute to PCC pathogenesis.